ClosedBusiness2021

MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity

Australian Government · Australia

The mRNA Clinical Trial Enabling Infrastructure grant provides $5 million over 3 years to support organisations to use and enhance emerging technologies, platforms, equipment and infrastructure for clinical trials of mRNA-based vaccines and/or therapeutics. It is part of the Medical Research Future Fund and supports Australia's onshore mRNA vaccine manufacturing capability.

Funding

$5M – $5M

Duration

3 years

Location

Australia

Who Can Apply

Must be an eligible organisation Must have applied to the 'Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability' program Must specify at least one state government partner organisation contributing to the research
Applicants must be an eligible organisation that applied to the Department of Industry, Science, Energy and Resources and the Department of Health's 'Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability' program. Applicants must also specify at least one state government partner organisation contributing to the research.

What's Funded

Using and enhancing emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and/or therapeutics, including activities that support onshore mRNA vaccine manufacturing capability.

Expected Outcomes

Enhanced clinical trial enabling infrastructure for mRNA-based vaccines and therapeutics, strengthened onshore mRNA manufacturing capability, and delivery of Australian medical research and medical innovation projects.

Key Information

Applicant Types

companyuniversityother

Stage

established

Funding Purposes

researchinnovationcapital_expenditure

Keywords

MRFFmRNAclinical trialsresearch infrastructurevaccinestherapeuticsmedical researchmedical innovation

Frequently Asked Questions

What is the MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity?

The MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity is a business grant offered by Australian Government in Australia, providing $5M – $5M in funding. The mRNA Clinical Trial Enabling Infrastructure grant provides $5 million over 3 years to support organisations to use and enhance emerging technologies, platforms, equipment and infrastructure for clinical trials of mRNA-based vaccines and/or therapeutics. It is part of the Medical Research Future Fund and supports Australia's onshore mRNA vaccine manufacturing capability.

How much funding does the MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity provide?

The MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity provides $5M – $5M in funding. The typical project duration is 3 years.

Who is eligible for the MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity?

Must be an eligible organisation Must have applied to the 'Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability' program Must specify at least one state government partner organisation contributing to the research

What activities are funded?

Using and enhancing emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and/or therapeutics, including activities that support onshore mRNA vaccine manufacturing capability.

How do I apply for the MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.